Bendavia

DRUG3 trials

Sponsors

Stealth BioTherapeutics Inc.

Conditions

Healthy VolunteersHypertension, RenovascularIschemia Reperfusion InjuryRenal Artery Obstruction

Phase 1

Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia

CompletedNCT01513200

Stealth BioTherapeutics Inc.Healthy Volunteers

Start: 2012-01-31End: 2012-02-29Updated: 2012-04-19

The Impact of Intravenous Bendavia™ on Endothelial Reactivity Dysfunction in Cigarette Smoking

CompletedNCT01518985

Stealth BioTherapeutics Inc.Healthy Volunteers

Start: 2012-01-31End: 2012-03-31Updated: 2012-04-19

Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery

TerminatedNCT01755858

Stealth BioTherapeutics Inc.Hypertension, Renovascular, Ischemia Reperfusion Injury, Renal Artery Obstruction

Start: 2012-12-31End: 2016-05-31Updated: 2020-08-11

Related Papers

Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis

Circulation Cardiovascular Interventions2017-09-01113 citations